Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AZN - FDA approves AstraZeneca's Tagrisso-chemo combo for advanced lung cancer

AZN - FDA approves AstraZeneca's Tagrisso-chemo combo for advanced lung cancer

AstraZeneca PLC

2024-02-19 02:06:33 ET

The U.S. Food and Drug Administration (FDA) has approved AstraZeneca's ( NASDAQ: AZN ) blockbuster cancer drug Tagrisso with chemotherapy for the treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC)....

For further details see:

FDA approves AstraZeneca's Tagrisso-chemo combo for advanced lung cancer
Stock Information
Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com
Menu
AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...